<DOC>
	<DOCNO>NCT01212471</DOCNO>
	<brief_summary>A dose ranging study evaluate safety efficacy bromfenac ophthalmic solution dry eye disease .</brief_summary>
	<brief_title>A Dose Ranging Study Evaluate Safety Efficacy Bromfenac Ophthalmic Solution Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Be either gender race 18 year old Have local systemic disease could interfere assessment safety efficacy likely result early discontinuation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Sign symptom dry eye disease</keyword>
</DOC>